117 related articles for article (PubMed ID: 7624149)
21. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
[TBL] [Abstract][Full Text] [Related]
22. Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9.
Cairns P; Shaw ME; Knowles MA
Oncogene; 1993 Apr; 8(4):1083-5. PubMed ID: 8096074
[TBL] [Abstract][Full Text] [Related]
23. Localization of an ovarian cancer tumor suppressor gene to a 0.5-cM region between D22S284 and CYP2D, on chromosome 22q.
Bryan EJ; Watson RH; Davis M; Hitchcock A; Foulkes WD; Campbell IG
Cancer Res; 1996 Feb; 56(4):719-21. PubMed ID: 8631002
[TBL] [Abstract][Full Text] [Related]
24. Allelotyping of anaplastic thyroid carcinoma: frequent allelic losses on 1q, 9p, 11, 17, 19p, and 22q.
Kitamura Y; Shimizu K; Tanaka S; Ito K; Emi M
Genes Chromosomes Cancer; 2000 Mar; 27(3):244-51. PubMed ID: 10679913
[TBL] [Abstract][Full Text] [Related]
25. Allelotype of papillary serous peritoneal carcinomas.
Cass I; Baldwin RL; Fasylova E; Fields AL; Klinger HP; Runowicz CD; Karlan BY
Gynecol Oncol; 2001 Jul; 82(1):69-76. PubMed ID: 11426964
[TBL] [Abstract][Full Text] [Related]
26. Allele loss from chromosome 17 in ovarian cancer.
Russell SE; Hickey GI; Lowry WS; White P; Atkinson RJ
Oncogene; 1990 Oct; 5(10):1581-3. PubMed ID: 2250914
[TBL] [Abstract][Full Text] [Related]
27. A frequent deletion polymorphism on chromosome 22q13 identified by representational difference analysis of ovarian cancer.
Lin H; Pizer ES; Morin PJ
Genomics; 2000 Nov; 69(3):391-4. PubMed ID: 11056057
[TBL] [Abstract][Full Text] [Related]
28. A novel region of deletion on chromosome 6q23.3 spanning less than 500 Kb in high grade invasive epithelial ovarian cancer.
Shridhar V; Staub J; Huntley B; Cliby W; Jenkins R; Pass HI; Hartmann L; Smith DI
Oncogene; 1999 Jul; 18(26):3913-8. PubMed ID: 10445856
[TBL] [Abstract][Full Text] [Related]
29. High-resolution 19p13.2-13.3 allelotyping of breast carcinomas demonstrates frequent loss of heterozygosity.
Yang TL; Su YR; Huang CS; Yu JC; Lo YL; Wu PE; Shen CY
Genes Chromosomes Cancer; 2004 Nov; 41(3):250-6. PubMed ID: 15334548
[TBL] [Abstract][Full Text] [Related]
30. Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors.
Saito H; Inazawa J; Saito S; Kasumi F; Koi S; Sagae S; Kudo R; Saito J; Noda K; Nakamura Y
Cancer Res; 1993 Jul; 53(14):3382-5. PubMed ID: 8100738
[TBL] [Abstract][Full Text] [Related]
31. Allelic deletion on chromosome 17p13.3 in early ovarian cancer.
Phillips NJ; Ziegler MR; Radford DM; Fair KL; Steinbrueck T; Xynos FP; Donis-Keller H
Cancer Res; 1996 Feb; 56(3):606-11. PubMed ID: 8564979
[TBL] [Abstract][Full Text] [Related]
32. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
[TBL] [Abstract][Full Text] [Related]
33. Frequent loss of heterozygosity on chromosome 14q in neuroblastoma.
Suzuki T; Yokota J; Mugishima H; Okabe I; Ookuni M; Sugimura T; Terada M
Cancer Res; 1989 Mar; 49(5):1095-8. PubMed ID: 2563671
[TBL] [Abstract][Full Text] [Related]
34. A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer.
Tangir J; Muto MG; Berkowitz RS; Welch WR; Bell DA; Mok SC
Oncogene; 1996 Feb; 12(4):735-40. PubMed ID: 8632895
[TBL] [Abstract][Full Text] [Related]
35. Loss of heterozygosity in familial breast carcinomas.
Lindblom A; Skoog L; Rotstein S; Werelius B; Larsson C; Nordenskjöld M
Cancer Res; 1993 Sep; 53(18):4356-61. PubMed ID: 8364930
[TBL] [Abstract][Full Text] [Related]
36. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status.
Mullokandov MR; Kholodilov NG; Atkin NB; Burk RD; Johnson AB; Klinger HP
Cancer Res; 1996 Jan; 56(1):197-205. PubMed ID: 8548763
[TBL] [Abstract][Full Text] [Related]
37. Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene.
Zenklusen JC; Weitzel JN; Ball HG; Conti CJ
Oncogene; 1995 Jul; 11(2):359-63. PubMed ID: 7624150
[TBL] [Abstract][Full Text] [Related]
38. Definition of a commonly deleted region in ovarian cancers to a 300-kb segment of chromosome 6q27.
Saito S; Sirahama S; Matsushima M; Suzuki M; Sagae S; Kudo R; Saito J; Noda K; Nakamura Y
Cancer Res; 1996 Dec; 56(24):5586-9. PubMed ID: 8971159
[TBL] [Abstract][Full Text] [Related]
39. Loss of heterozygosity on chromosomal segments 3p, 6q and 11p in human ovarian carcinomas.
Ehlen T; Dubeau L
Oncogene; 1990 Feb; 5(2):219-23. PubMed ID: 2320374
[TBL] [Abstract][Full Text] [Related]
40. Allelic loss on chromosome arm 8p: analysis of sporadic epithelial ovarian tumors.
Brown MR; Chuaqui R; Vocke CD; Berchuck A; Middleton LP; Emmert-Buck MR; Kohn EC
Gynecol Oncol; 1999 Jul; 74(1):98-102. PubMed ID: 10385558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]